Dopa-induced blood flow responses in nonhuman primates

Experimental Neurology

Volumn 166, Issue 2, 2000, Pages 342-349

  Hershey, Tamara ^a   Black, Kevin J ^a,b   Carl, Juanita L ^a   Perlmutter, Joel S ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood flow; Dopaminergic pathways; Levodopa; Nonhuman primates; Parkinson's disease; PET

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; BRAIN BLOOD FLOW; CONTROLLED STUDY; DISEASE COURSE; DOPAMINERGIC SYSTEM; DRUG RESPONSE; FRONTAL CORTEX; INVOLUNTARY MOVEMENT; LONGITUDINAL STUDY; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; PUTAMEN; SYMPTOMATOLOGY;

EID: 0033663868     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7522     Document Type: Article

References (44)

1. Cerebral pharmacodynamics of anaesthetic and subanaesthetic doses of ketamine in the normoventilated pig
2. Pharmacokinetics and related pharmacodynamics of anticholinergic drugs
3. Simple and rapid micromethod for the determination of levodopa and 3-O-methyldopa in human plasma by high-performance liquid chromotography with coulometric detection
4. Dopaminergic innervation of the cerebral cortex: Unexpected differences between rodents and primates
5. Diffuse temporal lobe activation by a dopamine D1 full agonist in living primates
6. PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function
7. Baboon basal ganglia stereotaxy using internal MRI landmarks: Validation and application to PET imaging
8. An in vivo test of striatopallidal sensitivity to a specific D2 agonist
9. A metric for testing the accuracy of cross-modality image registration: Validation and application
10. In vivo regional cerebral blood flow responses to a dopamine D1 agonist
11. Apomorphine increases glucose utilization in the substantia nigra, subthalamic nucleus and corpus striatum of rat
12. Functional MRI of basal ganglia responsiveness to levodopa in parkinsonian rhesus monkeys
13. N-Methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion
14. 15O tissue activity
15. Detecting activations in PET and fMRI: Levels of inference and power
16. The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers
17. The effects of chloral hydrate anaesthesia on the metabolic response in the substantia nigra to apomorphine
18. The effects of apomorphine upon local cerebral glucose utilization in conscious rats, and rats anaesthetized with chloral hydrate
19. In vivo imaging of human limbic responses to nitrous oxide inhalation
20. Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers
21. 133xenon before and after levodopa
22. 15O. I. Theory and error analysis
23. Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias
24. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin
25. Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders
26. Ketamine-induced effects on behavior and rCBF is enhanced in schizophrenic compared to normal individuals
27. The cerebral effects of pancuronium and atracurium in halothaneanesthetized dogs
28. The effects of L-dopa on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease
29. Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis)
30. The dose-response relationship for memory impairment by anticholinergic drugs
31. Regional cerebral blood flow in Parkinsonism
32. Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures
33. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia
34. Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease
35. PET measurements of dopaminergic pathways in the brain
36. Regional blood flow in hemiparkinsonism
37. PET measured evoked cerebral blood flow responses in an awake monkey
38. 15O. II. Implementation and validation
39. Simultaneous determination of levodopa methylester, levodopa, 3-O-methyldopa and dopamine in plasma by high-performance liquid chromotography with electrochemical detection
40. Physical performance of a positron tomograph for brain imaging with retractable septa
41. The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra
42. Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization inrats with unilateral 6-hydroxydopamine substantia nigra lesions
43. Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease
44. Brain blood volume, flow and oxygen utilization measured with O-15 radiotracers and positron emission tomography: Revised metabolic computations